Please login to the form below
Torii
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.
Myovant preps US filing for relugolix in prostate cancer
of 2020 and in Europe and Japan a little later, says the biotech.
FDA advisors say no to empagliflozin in type 1 diabetes
Europe as well as Japan.
Pharmaceutical innovation in the APAC region
We examined these factors for Mainland China, Japan and South Korea, concluding, very broadly:. ... Cancer will remain a growth market, although Japan is currently experiencing price containment pressures that other countries will also ultimately face.
Sandoz expands into Japan with €400m Aspen deal
The acquisition will include shares in Aspen Japan K.K. and all associated assets held by AGI. ... Japan’s generic medicines market is the third largest globally, a fact which will aid Sandoz’ continuing growth – in Novartis’ recent third
Daiichi files lawsuit with Seattle over ADCs, including AZ-partnered DS-8201
Dispute covers multiple drugs in Daiichi's antibody-drug conjugates pipeline. A partnership between Seattle Genetics and Japan’s Daiichi Sankyo on antibody-drug conjugates, which ended in 2015, has sparked
[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- AZ strengthens Daiichi Sankyo partnership with new ADC deal
- Novavax reports promising phase 1 results for coronavirus vaccine
- China’s CanSino Biologics reveals phase 2 coronavirus vaccine results
- AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
- How will the events and exhibitions industry change post-Coronavirus?
- Novartis builds its case for novel MS treatment ofatumumab
- Planning your clinical trial? Why you need to engage patients sooner
- Live Webinar: Re imagining Healthcare through Integrated Digital Health Empowerment
- Combating Coronavirus Through Reversing Diabetes
- Delivering safe and effective clinical trials during the COVID-19 pandemic
- Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi
- Biogen’s highly-anticipated Alzheimer’s drug wins FDA fast-track
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...
Latest intelligence
- Planning your clinical trial? Why you need to engage patients sooner
- It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
- Patient-centricity in improving patient recruitment advertising
- This blog looks into the importance of concepts and patient centricity in patient recruitment....
- AI: the smart money is on the smart thinking
- Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Quick links
Infographics
